Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane phospholipids are essential structural components of the cytoplasmic membranes in bacteria and fungi, providing a semi-permeable barrier that maintains cellular homeostasis and regulates ion transport (StatPearls, 2023). These lipids, which include phosphatidylglycerol, phosphatidylethanolamine, and cardiolipin, differ significantly in charge and composition from the neutral phospholipids found in mammalian cell membranes, allowing for selective pharmacological targeting (PubMed, PMC4584998). Antibiotics such as daptomycin and polymyxins target these phospholipids to induce membrane depolarization, pore formation, and physical disruption of the bilayer (Nature Reviews Microbiology, 2017). This disruption leads to the rapid leakage of essential intracellular components like potassium ions, resulting in cell death. Because these targets are structural rather than metabolic, they are effective against both actively growing and stationary phase bacteria, including many multi-drug resistant (MDR) strains (NIH, 2022). However, the clinical use of membrane-targeting drugs is often limited by potential toxicity to host tissues, such as nephrotoxicity and myopathy, requiring careful monitoring of patient biomarkers (PubMed, PMC7072114).
Binding to and disruption of the lipid bilayer, leading to pore formation, membrane depolarization, and leakage of cytoplasmic contents.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane phospholipids.